| Primary |
| Alcoholism |
25.0% |
| Cardiac Failure |
25.0% |
| Depression |
25.0% |
| Hypertension |
25.0% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
40.0% |
| Thrombosis Prophylaxis |
6.4% |
| Sleep Disorder |
5.5% |
| Hypertension |
4.2% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Hypokalaemia |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Hyperthyroidism |
3.3% |
| Essential Hypertension |
3.2% |
| Diabetes Mellitus |
3.0% |
| Agitation |
2.9% |
| Supraventricular Tachycardia |
2.7% |
| Epilepsy |
2.6% |
| Fluid Replacement |
2.5% |
| Polyuria |
2.5% |
| Nausea |
2.4% |
| Dermatitis |
2.2% |
| Rash |
2.2% |
| Pneumonia |
2.1% |
| Hyperuricaemia |
2.0% |
|
| Swollen Tongue |
13.5% |
| Toxic Epidermal Necrolysis |
13.5% |
| Therapeutic Agent Toxicity |
10.1% |
| Urine Colour Abnormal |
9.0% |
| Suicide Attempt |
6.7% |
| Rhabdomyolysis |
4.5% |
| Atrioventricular Block |
3.4% |
| Circulatory Collapse |
3.4% |
| Death |
3.4% |
| Enuresis |
3.4% |
| Hyperventilation |
3.4% |
| Renal Failure |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Tachycardia |
3.4% |
| Torticollis |
3.4% |
| Vomiting |
3.4% |
| Acute Hepatic Failure |
2.2% |
| Hepatic Necrosis |
2.2% |
| Ileus Paralytic |
2.2% |
| Pallor |
2.2% |
|
| Concomitant |
| Encephalitis |
13.9% |
| Hypertension |
11.4% |
| Product Used For Unknown Indication |
11.4% |
| Dementia |
9.4% |
| Sepsis |
5.0% |
| Renal Transplant |
4.5% |
| Collateral Circulation |
4.0% |
| Pulmonary Embolism |
4.0% |
| Constipation |
3.5% |
| Ear Infection |
3.5% |
| Renal Failure |
3.5% |
| Thrombosis Prophylaxis |
3.5% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Depression |
3.0% |
| Hallucination |
3.0% |
| Prophylaxis |
3.0% |
| Sleep Disorder |
3.0% |
| Toxoplasmosis |
3.0% |
| Glioblastoma Multiforme |
2.5% |
| Pain |
2.5% |
|
| Hyponatraemia |
15.1% |
| Somnolence |
11.3% |
| Status Epilepticus |
7.5% |
| Tachycardia |
7.5% |
| Atrial Fibrillation |
5.7% |
| Thrombocytopenia |
5.7% |
| Agitation |
3.8% |
| Clostridium Difficile Colitis |
3.8% |
| Hepatic Failure |
3.8% |
| Infection |
3.8% |
| Nausea |
3.8% |
| Necrosis |
3.8% |
| Rash Macular |
3.8% |
| Rhabdomyolysis |
3.8% |
| Sleep Disorder |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Withdrawal Syndrome |
3.8% |
| Accidental Exposure |
1.9% |
| Bone Marrow Toxicity |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
66.3% |
| Product Used For Unknown Indication |
17.8% |
| Mania |
3.7% |
| Prophylaxis |
3.7% |
| Schizoaffective Disorder |
3.7% |
| Cardiac Disorder |
2.5% |
| Dementia |
0.6% |
| Depression |
0.6% |
| Psychotic Disorder |
0.6% |
| Tooth Extraction |
0.6% |
|
| Renal Failure |
37.5% |
| Drug Interaction |
16.7% |
| Right Atrial Dilatation |
12.5% |
| Neutropenia |
8.3% |
| Enuresis |
4.2% |
| Hypokalaemia |
4.2% |
| Oropharyngeal Spasm |
4.2% |
| Restlessness |
4.2% |
| Shock |
4.2% |
| Vertigo |
4.2% |
|
